Site Map — PartitionBio | Next-Gen Drug Delivery Using Biomolecular Condensates

Skip to Content

Product Documentation

Product Documentation

Folder: Products

Product Documentation

Folder: Resources

Folder: Contact

Main Pages:

Alpha & Beta Programme
Blog
BubbleFect [Buy Now]
Contact Us
Cookie Policy
Data
Downloads Archive
FAQs
Feedback
Help Desk
Home [PartitionBio]
Privacy Policy
Product Documentation [Downloads]
Protocols
Returns Policy
Shipping Information
Store
Team
Technology
Testimonials
Thank you

Blog Posts:

Why Non-Viral Delivery Is the Future of Therapeutics
Rethinking Lipid Nanoparticles
Understanding Liquid-Liquid Phase Separation
PartitionBio at ELRIG Drug Discovery 2025 — Innovation Zone
PartitionBio and Gene Weaver Announce Exclusive Partnership
BubbleFect Wins ELRIG Drug Discovery 2025 Innovation Award
ELRIG Drug Discovery 2025: Innovation, Inspiration, and an Unforgettable Week
PartitionBio: 2025 in Review
PartitionBio at ELRIG Cell & Gene Therapy 2026
PartitionBio at SLAS Europe 2026, Vienna

PartitionBio is a UK-based biotech company developing next-generation drug delivery systems using biomolecular condensates formed through liquid-liquid phase separation (LLPS). Their non-viral platform enables efficient delivery of macromolecules like nucleic acids and proteins into human cells, aiming to improve therapeutic outcomes. PartitionBio is advancing accessible solutions for global health.

Address:
Sigma House, Level 2, Unity Campus, 40 South Street, Cambridge CB22 3FW

Tel: +44 (0) 1799 243060

Privacy Policy Cookie Policy